Success Metrics

Clinical Success Rate
91.1%

Based on 51 completed trials

Completion Rate
91%(51/56)
Active Trials
3(4%)
Results Posted
37%(19 trials)
Terminated
5(7%)

Phase Distribution

Ph phase_4
16
24%
Ph not_applicable
13
19%
Ph phase_1
13
19%
Ph phase_3
10
15%
Ph early_phase_1
5
7%
Ph phase_2
8
12%

Phase Distribution

18

Early Stage

8

Mid Stage

26

Late Stage

Phase Distribution65 total trials
Early Phase 1First-in-human
5(7.7%)
Phase 1Safety & dosage
13(20.0%)
Phase 2Efficacy & side effects
8(12.3%)
Phase 3Large-scale testing
10(15.4%)
Phase 4Post-market surveillance
16(24.6%)
N/ANon-phased studies
13(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.1%

51 of 56 finished

Non-Completion Rate

8.9%

5 ended early

Currently Active

3

trials recruiting

Total Trials

67

all time

Status Distribution
Active(4)
Completed(51)
Terminated(5)
Other(7)

Detailed Status

Completed51
unknown7
Terminated5
Recruiting2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
67
Active
3
Success Rate
91.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (7.7%)
Phase 113 (20.0%)
Phase 28 (12.3%)
Phase 310 (15.4%)
Phase 416 (24.6%)
N/A13 (20.0%)

Trials by Status

completed5176%
not_yet_recruiting11%
recruiting23%
terminated57%
active_not_recruiting11%
unknown710%

Recent Activity

Clinical Trials (67)

Showing 20 of 67 trialsScroll for more
NCT05540574Phase 2

Trial of Zolpidem for Sleep in Children With Autism

Recruiting
NCT07336277Phase 3

Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

Not Yet Recruiting
NCT04014387Phase 4

Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)

Completed
NCT06975514Phase 3

Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

Recruiting
NCT03375203Phase 2

A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder

Completed
NCT05106153Phase 1

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Completed
NCT04273776Early Phase 1

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Active Not Recruiting
NCT04468776Phase 4

CBT-I or Zolpidem/Trazodone for Insomnia

Completed
NCT03436745Phase 1

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Completed
NCT03657212Phase 4

Enhancing Memory Consolidation in Older Adults

Terminated
NCT06512155Phase 1

Improving Perioperative Sleep Disorders

Completed
NCT06685341Phase 1

PK/PD Study of YZJ-1139

Completed
NCT06244277Not Applicable

Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal

Unknown
NCT04720547Phase 4

Sleep and Breathing in the General Population - Chemical Stimuli

Completed
NCT04692285Phase 1

Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia

Completed
NCT06084130Phase 4

Zolpidem on CPAP Acclimatization in OSA

Unknown
NCT05615727Phase 3

Intranasal Dexmedetomidine and Zolpidem for Treatment of Primary Insomnia

Unknown
NCT00777829Not Applicable

Memory Consolidation in Pharmacologically Enhanced Naps

Completed
NCT01651442Not Applicable

Sequenced Therapies for Comorbid and Primary Insomnias

Completed
NCT04102345Early Phase 1

Lavender vs Zolpidem Sleep Quality During Diagnostic PSG

Completed

Drug Details

Intervention Type
DRUG
Total Trials
67